Sorbel, Jeff

Publishing since 2004 (Junior)

Has published 8 publications in 5 years

Number of publications published per year by Sorbel, Jeff. (Source : PubMed)

Distribution of publications types for Sorbel, Jeff. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)

Recent publications

Marcellin P, Heathcote EJ, Buti M, Gane E, de Man RA, Krastev Z, Germanidis G, Lee SS, Flisiak R, Kaita K, Manns M, Kotzev I, Tchernev K, Buggisch P, Weilert F, Kurdas OO, Shiffman ML, Trinh H, Washington MK, Sorbel J, Anderson J, Snow-Lampart A, Mondou E, Quinn J, Rousseau F. Tenofovir disoproxil fumarate versus adefovir dipivoxil for chronic hepatitis B. N. Engl. J. Med. 2008;359;23
Wu IC, Shiffman ML, Tong MJ, Marcellin P, Mondou E, Frederick D, Snow-Lampart A, Sorbel J, Rousseau F, Chang TT. Sustained hepatitis B e antigen seroconversion in patients with chronic hepatitis B after adefovir dipivoxil treatment: analysis of precore and basal core promoter mutants. Clin. Infect. Dis. 2008;47;10
Lim SG, Leung N, Hann HW, Lau GK, Trepo C, Mommeja-Marin H, Moxham C, Sorbel J, Snow A, Blum MR, Rousseau F, Marcellin P. Clinical trial: a phase II, randomized study evaluating the safety, pharmacokinetics and anti-viral activity of clevudine for 12 weeks in patients with chronic hepatitis B. Aliment. Pharmacol. Ther. 2008;27;12
Jonas MM, Kelly D, Pollack H, Mizerski J, Sorbel J, Frederick D, Mondou E, Rousseau F, Sokal E. Safety, efficacy, and pharmacokinetics of adefovir dipivoxil in children and adolescents (age 2 to <18 years) with chronic hepatitis B. Hepatology 2008;47;6
Lau GK, Cooksley H, Ribeiro RM, Powers KA, Shudo E, Bowden S, Hui CK, Anderson J, Sorbel J, Mondou E, Rousseau F, Lewin S, Perelson AS, Locornini S, Naoumov NV. Impact of early viral kinetics on T-cell reactivity during antiviral therapy in chronic hepatitis B. Antivir. Ther. (Lond.) 2007;12;5
Lim SG, Ng TM, Kung N, Krastev Z, Volfova M, Husa P, Lee SS, Chan S, Shiffman ML, Washington MK, Rigney A, Anderson J, Mondou E, Snow A, Sorbel J, Guan R, Rousseau F. A double-blind placebo-controlled study of emtricitabine in chronic hepatitis B. Arch. Intern. Med. 2006;166;1
Mondou E, Sorbel J, Anderson J, Mommeja-Marin H, Rigney A, Rousseau F. Posttreatment exacerbation of hepatitis B virus (HBV) infection in long-term HBV trials of emtricitabine. Clin. Infect. Dis. 2005;41;5
Gish RG, Trinh H, Leung N, Chan FK, Fried MW, Wright TL, Wang C, Anderson J, Mondou E, Snow A, Sorbel J, Rousseau F, Corey L. Safety and antiviral activity of emtricitabine (FTC) for the treatment of chronic hepatitis B infection: a two-year study. J. Hepatol. 2005;43;1
Marcellin P, Mommeja-Marin H, Sacks SL, Lau GK, Sereni D, Bronowicki JP, Conway B, Trepo C, Blum MR, Yoo BC, Mondou E, Sorbel J, Snow A, Rousseau F, Lee HS. A phase II dose-escalating trial of clevudine in patients with chronic hepatitis B. Hepatology 2004;40;1

[ See timeline ] [ See all publications ]

h=13

means that Sorbel, Jeff has 13 papers cited a least 13 times - methodology

Key figures

8 pub in 5 years
1.6 publications/year
best year 2008 with 3 pub
h-index 13 with 8 pub
h-ratio : 162 %

See Timeline

Ranking

It's me !

Click here if you are
Sorbel, Jeff.

Most frequent Journals

Clin. Infect. Dis. (2x)
Alcohol. Clin. Exp. Res. (2x)
Hepatology (2x)
Antivir. Ther. (Lond.) (1x)
Genet. Epidemiol. (1x)

Main affiliation

Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan, Republic of China.

Latest co-workers

Anderson J Blum MR Frederick D Germanidis G Kaita K Krastev Z Lau GK Lee SS Marcellin P Mommeja-Marin H Mondou E Rigney A Rousseau F Shiffman ML Snow A Snow-Lampart A Trinh H Washington MK Wu IC de Man RA

Back to HepaTop

Due mainly to homonyms, errors are possible and if you detect "false positives" or "false negatives" don't be too frustrated and please contact the webmaster.